Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sen. Susan Collins and Sen. Joe Manchin in February 2018 in Washington, D.C. Photo: Alex Wong/Getty Images

A bipartisan group of lawmakers on Wednesday released a detailed outline of their $908 billion coronavirus stimulus proposal, according to a copy of the draft legislation obtained by Axios.

Details: The proposal includes an extension of enhanced unemployment insurance benefits by 16 weeks, but it does not include provisions on direct payments to individuals, increased funding for state and local governments, or detailed language on liability protections — some of the most disputed aspects under negotiation by both parties.

  • On liability protections — a top priority for Republicans — the proposal says there is "An agreement in principle as the basis for good faith negotiations."

Timing: The outline comes hours after Treasury Secretary Steven Mnuchin announced a $916 billion White House plan.

  • The White House version severely cuts the extended unemployment benefits negotiated by the bipartisan group, but does includes $600 stimulus checks as well as additional funding for state and local governments and a liability shield for businesses.
  • Mnuchin pitched the plan to House Speaker Nancy Pelosi and Republican leadership on Tuesday.
  • Pelosi and Senate Minority Leader Chuck Schumer immediately rejected the plan as insufficient, while Senate Majority Leader Mitch McConnell and House Republican Leader Kevin McCarthy signaled their support.

What they're saying: McConnell criticized Democrats on Wednesday for trying to "kill any compromise" on a stimulus deal after Pelosi and Schumer rejected two Republican proposals yesterday.

  • But the Democratic leaders say they do support the $908 billion bipartisan deal.

Read the framework.

Go deeper

Updated Oct 16, 2021 - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Booster shots overtake first doses in the U.S. — Pfizer to vaccinate entire Brazilian city as part of study — FDA panel endorses shot of J&J booster for adultsU.S. to lift restrictions for fully vaccinated international travelers on Nov. 8.
  2. Health: New cases down, but the West is at risk — Low vaccination rates exacerbate America's caregiving crisis — COVID is here to stay. So what does "victory" look like? — FDA will review Merck COVID-19 pill.
  3. Politics: NHL announces all but four players have been vaccinated — WHO names new advisory group on COVID origins — Biden admin warns Moderna to "step up" global vaccine supply.
  4. Education: LA extends deadline for school employee vaccinations amid staffing shortage — Parent sues Wisconsin school district after child tests positive — Arizona can't use aid for anti-mask education grants, Treasury says.
  5. Variant tracker: Where different strains are spreading.
Jan 30, 2021 - World

Science helps New Zealand avoid another coronavirus lockdown

New Zealand Prime Minister Jacinda Ardern (L) visits a lab at Auckland University in December. Photo: Phil Walter/Getty Images

New Zealand has avoided locking down for a second time over COVID-19 community cases because of a swift, science-led response.

Why it matters: The Health Ministry said in an email to Axios Friday there's "no evidence of community transmission" despite three people testing positive after leaving managed hotel isolation. That means Kiwis can continue to visit bars, restaurants and events as much of the world remains on lockdown.

Jan 29, 2021 - Health

WHO says most pregnant women can now receive coronavirus vaccine

A doctor administering Moderna's coronavirus vaccine at a university hospital in Essen, Germany, on Jan. 18. Photo: Lukas Schulze/Getty Images

The World Health Organization has altered its guidance for pregnant women who wish to receive the coronavirus vaccine, saying now that those at high risk of exposure to the COVID-19 or who have comorbidities that increase their risk of severe disease, may be vaccinated.

Why it matters: The WHO drew backlash for its previous guidance that did not recommend pregnant women be inoculated with vaccines made by Pfizer-BioNTech or Moderna, even though data indicated that pregnancy increased the risk of developing severe illness from the virus.